Copyright Reports & Markets. All rights reserved.

Global and China Psoriatic Arthritis Drug Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Psoriatic Arthritis Drug Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 TNF Inhibitors
    • 1.2.3 PDE4 Inhibitors
    • 1.2.4 Interleukin Blockers
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Psoriatic Arthritis Drug Market Share by Application: 2020 VS 2026
    • 1.3.2 Mild Psoriatic Arthritis
    • 1.3.3 Moderate Psoriatic Arthritis
    • 1.3.4 Severe Psoriatic Arthritis
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Psoriatic Arthritis Drug Market Perspective (2015-2026)
  • 2.2 Global Psoriatic Arthritis Drug Growth Trends by Regions
    • 2.2.1 Psoriatic Arthritis Drug Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Psoriatic Arthritis Drug Historic Market Share by Regions (2015-2020)
    • 2.2.3 Psoriatic Arthritis Drug Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Psoriatic Arthritis Drug Players by Market Size
    • 3.1.1 Global Top Psoriatic Arthritis Drug Players by Revenue (2015-2020)
    • 3.1.2 Global Psoriatic Arthritis Drug Revenue Market Share by Players (2015-2020)
  • 3.2 Global Psoriatic Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Psoriatic Arthritis Drug Revenue
  • 3.4 Global Psoriatic Arthritis Drug Market Concentration Ratio
    • 3.4.1 Global Psoriatic Arthritis Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Drug Revenue in 2019
  • 3.5 Key Players Psoriatic Arthritis Drug Area Served
  • 3.6 Key Players Psoriatic Arthritis Drug Product Solution and Service
  • 3.7 Date of Enter into Psoriatic Arthritis Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Psoriatic Arthritis Drug Breakdown Data by Type (2015-2026)

  • 4.1 Global Psoriatic Arthritis Drug Historic Market Size by Type (2015-2020)
  • 4.2 Global Psoriatic Arthritis Drug Forecasted Market Size by Type (2021-2026)

5 Psoriatic Arthritis Drug Breakdown Data by Application (2015-2026)

  • 5.1 Global Psoriatic Arthritis Drug Historic Market Size by Application (2015-2020)
  • 5.2 Global Psoriatic Arthritis Drug Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Psoriatic Arthritis Drug Market Size (2015-2026)
  • 6.2 North America Psoriatic Arthritis Drug Market Size by Type (2015-2020)
  • 6.3 North America Psoriatic Arthritis Drug Market Size by Application (2015-2020)
  • 6.4 North America Psoriatic Arthritis Drug Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Psoriatic Arthritis Drug Market Size (2015-2026)
  • 7.2 Europe Psoriatic Arthritis Drug Market Size by Type (2015-2020)
  • 7.3 Europe Psoriatic Arthritis Drug Market Size by Application (2015-2020)
  • 7.4 Europe Psoriatic Arthritis Drug Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Psoriatic Arthritis Drug Market Size (2015-2026)
  • 8.2 China Psoriatic Arthritis Drug Market Size by Type (2015-2020)
  • 8.3 China Psoriatic Arthritis Drug Market Size by Application (2015-2020)
  • 8.4 China Psoriatic Arthritis Drug Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Psoriatic Arthritis Drug Market Size (2015-2026)
  • 9.2 Japan Psoriatic Arthritis Drug Market Size by Type (2015-2020)
  • 9.3 Japan Psoriatic Arthritis Drug Market Size by Application (2015-2020)
  • 9.4 Japan Psoriatic Arthritis Drug Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Psoriatic Arthritis Drug Market Size (2015-2026)
  • 10.2 Southeast Asia Psoriatic Arthritis Drug Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Psoriatic Arthritis Drug Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Psoriatic Arthritis Drug Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbvie
    • 11.1.1 Abbvie Company Details
    • 11.1.2 Abbvie Business Overview
    • 11.1.3 Abbvie Psoriatic Arthritis Drug Introduction
    • 11.1.4 Abbvie Revenue in Psoriatic Arthritis Drug Business (2015-2020))
    • 11.1.5 Abbvie Recent Development
  • 11.2 Janssen
    • 11.2.1 Janssen Company Details
    • 11.2.2 Janssen Business Overview
    • 11.2.3 Janssen Psoriatic Arthritis Drug Introduction
    • 11.2.4 Janssen Revenue in Psoriatic Arthritis Drug Business (2015-2020)
    • 11.2.5 Janssen Recent Development
  • 11.3 Amgen
    • 11.3.1 Amgen Company Details
    • 11.3.2 Amgen Business Overview
    • 11.3.3 Amgen Psoriatic Arthritis Drug Introduction
    • 11.3.4 Amgen Revenue in Psoriatic Arthritis Drug Business (2015-2020)
    • 11.3.5 Amgen Recent Development
  • 11.4 Pfizer
    • 11.4.1 Pfizer Company Details
    • 11.4.2 Pfizer Business Overview
    • 11.4.3 Pfizer Psoriatic Arthritis Drug Introduction
    • 11.4.4 Pfizer Revenue in Psoriatic Arthritis Drug Business (2015-2020)
    • 11.4.5 Pfizer Recent Development
  • 11.5 Eli-lilly
    • 11.5.1 Eli-lilly Company Details
    • 11.5.2 Eli-lilly Business Overview
    • 11.5.3 Eli-lilly Psoriatic Arthritis Drug Introduction
    • 11.5.4 Eli-lilly Revenue in Psoriatic Arthritis Drug Business (2015-2020)
    • 11.5.5 Eli-lilly Recent Development
  • 11.6 Celgene
    • 11.6.1 Celgene Company Details
    • 11.6.2 Celgene Business Overview
    • 11.6.3 Celgene Psoriatic Arthritis Drug Introduction
    • 11.6.4 Celgene Revenue in Psoriatic Arthritis Drug Business (2015-2020)
    • 11.6.5 Celgene Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Psoriatic Arthritis Drug Scope and Market Size
    Psoriatic Arthritis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriatic Arthritis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    TNF Inhibitors
    PDE4 Inhibitors
    Interleukin Blockers
    Other

    Market segment by Application, split into
    Mild Psoriatic Arthritis
    Moderate Psoriatic Arthritis
    Severe Psoriatic Arthritis

    Based on regional and country-level analysis, the Psoriatic Arthritis Drug market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Psoriatic Arthritis Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbvie
    Janssen
    Amgen
    Pfizer
    Eli-lilly
    Celgene
    ...

    Buy now